Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial at ESMO Immuno-Oncology & Advanced Therapies Congress 2026

The Quick Take
Dr. Robert Wenham, principal investigator of Anixa's Phase 1 clinical trial at Moffitt Cancer Center, to present on December 14 in London SAN JOSE, Calif., Nov. 4, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Business
Ceva Welcomes Introduction of Bluetooth High Data Throughput, Accelerating Next-Generation Wireless Connectivity
Early investment in Bluetooth HDT, integrated RF capabilities and proven interoperability drive strong commercial momentum, with more than ten customers…
Business
U.S. Air Force Awards Exiger $12 Million Contract to Support Intercontinental Ballistic Missile Supply Chain Illumination and Defense Industrial Base Analysis
Exiger to provide parts-level intelligence, supplier risk monitoring, and industrial base analytics for the ICBM enterprise to support the U.S. ground-based…
Business
Chicago's Business Community Rallies for Kids: FirstService Residential and In Good Company Partners Raise $65,000 for Lurie Children's Hospital
14th Annual IGC Vendor Expo turns a day of connection into lasting support for children and families, lifting total giving to more than $375,000 since 2017.…
Business
Satisfi Labs Awarded Two U.S. Patents That Lay the Foundation for Satisfi Forward
Patented platform capabilities, developed over years of client deployments, give clients control over what their AI Agents say and put the data they already…
